Differential expression profile and genetic variants of MicroRNAs sequences in breast cancer patients

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Alshatwi, Ali A ^a   Shafi, Gowhar ^a   Hasan, Tarique N ^a   Syed, Naveed Ahmed ^a   Al Hazzani, Amal A ^b   Alsaif, Mohammed A ^c   Alsaif, Abdulaziz A ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 196A2; MICRORNA 499; RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HS MIRNA 146A GENE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BREAST TUMOR; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPING TECHNIQUE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; RISK;

ADULT; ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; GENOTYPING TECHNIQUES; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POSTMENOPAUSE;

EID: 84857407573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030049     Document Type: Article

References (28)

1. Bin ASM, Maqbool Z, Nirmal MS, Qattan AT, Hussain SS, et al. (2008) Gene expression profiling in women with breast cancer in Saudi population. Saudi Med J 29: 507-513.
2. Elkum N, Dermime S, Tulbah A, Ajarim D, Almalik O, et al. (2007) Age 40 and younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience. BMC Cancer 7: 222.
3. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136 (2): 215-33.
4. Li LC, (2008) The multifaceted small RNAs. RNA Biol 5 (2): 61-64.
5. Mocellin S, Pasquali S, Pilati P, (2009) Oncomirs: from tumor biology to molecularly targeted anticancer strategies. Mini Rev Med Chem 9 (1): 70-80.
6. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451 (7182): 1125-1129.
7. Merkerova M, Belickova M, Bruchova H, (2008) Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 81 (4): 304-10.
8. Aumiller V, Forstemann K, (2008) Roles of microRNAs beyond development-metabolism and neural plasticity. Biochim Biophys Acta 1779 (11): 692-6.
9. Carissimi C, Fulci V, Macino G, (2009) MicroRNAs: Novel regulators of immunity. Autoimmun Rev 8 (6): 520-524.
10. Shafi G, Nishat A, Anjana M, (2010) MicroRNA Signatures in Neurological Disorders. The Canadian Journal of Neurological Sciences 37 (2): 177-185.
11. Bushati N, Cohen SM, (2008) MicroRNAs in neurodegeneration. Curr Opin Neurobiol 18 (3): 292-6.
12. Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, et al. (2007) MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121 (5): 1156-61.
13. Nelson PT, Wang WX, Rajeev BW, (2008) MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18 (1): 130-8.
14. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 30 untranslated region increases non-small cell lung cancer risk. Cancer Res 68: 8535-40.
15. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 105: 7269-74.
16. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18 (10): 997-1006.
17. Alshatwi AA, Tarique NH, Gowhar S, Mohammed AA, Amal AA, et al. (2011) A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol doi:10.1111/j.1472-8206.2011.00939.
18. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.
19. Yu Z, Li Z, Jolicoeur N, et al. (2007) Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res 35: 4535-41.
20. Van HLP, Ruijs MW, Wagner A, et al. (2007) Two TP53 germline mutations in a classical Li-Fraumeni syndrome family. Fam Cancer 6: 311-6.
21. Croce CM, Calin GA, (2005) miRNAs, cancer, and stem cell division. Cell 122: 6-7.
22. Calin GA, Manuel F, Amelia C, Gianpiero DL, Masayoshi S, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
23. Raveche ES, Erica S, Brain JS, Vijaya M, Fatima A, et al. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109: 5079-5086.
24. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
25. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908.
26. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
27. Couzin J, (2008) MicroRNAs make big impression in disease after disease. Science 319: 1782-1784.
28. Urbich C, Kuehbacher A, Dimmeler S, (2008) Role of microRNAs in vascular diseases, inflammation and angiogenesis. Cardiovasc Res 79 (4): 581-8.